Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype.
A PI3Kα-selective inhibitor has recently been approved for use in breast tumors harboring mutations in PIK3CA, the gene encoding p110α. Preclinical studies have suggested that the PI3K/AKT/mTOR signaling pathway influences stemness, a dedifferentiation-related cellular phenotype associated with aggr...
Saved in:
| Main Authors: | Ralitsa R Madsen, Emily C Erickson, Oscar M Rueda, Xavier Robin, Carlos Caldas, Alex Toker, Robert K Semple, Bart Vanhaesebroeck |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-11-01
|
| Series: | PLoS Genetics |
| Online Access: | https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1009876&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncogenic PIK3CA corrupts growth factor signaling specificity
by: Ralitsa R Madsen, et al.
Published: (2024-12-01) -
The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma
by: Ilaria Versari, et al.
Published: (2025-02-01) -
PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment
by: Mingyang Jiang, et al.
Published: (2025-08-01) -
Association of Genetic Variations in The PIK3-AKT-mTOR Pathway with Endometriosis Susceptibility: A Preliminary Case-Control Study
by: Rahele Ghasemian Moghadam, et al.
Published: (2025-04-01) -
AURKB and PI3K/AKT/mTOR pathways converge to regulate TERT expression
by: Grace Lim, et al.
Published: (2025-08-01)